0 XP   0   0   0

Dermapharm Holding SE










Financial Health of Dermapharm Holding SE




Comparing to competitors in the industry




  Industry Rankings  


Dermapharm Holding SE
Buy, Hold or Sell?

Should you buy, hold or sell Dermapharm Holding SE?

I guess you are interested in Dermapharm Holding SE. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Dermapharm Holding SE

Let's start. I'm going to help you getting a better view of Dermapharm Holding SE. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Dermapharm Holding SE even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Dermapharm Holding SE is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Dermapharm Holding SE. The closing price on 2022-12-07 was €39.60 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Dermapharm Holding SE Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

1.1. Profitability of Dermapharm Holding SE.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dermapharm Holding SE earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Dermapharm Holding SE to the  industry mean.
  • A Net Profit Margin of 6.1% means that €0.06 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dermapharm Holding SE:

  • The MRQ is 6.1%. The company is making a profit. +1
  • The TTM is 18.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ6.1%TTM18.5%-12.4%
TTM18.5%5Y18.5%0.0%
5Y18.5%10Y18.5%0.0%
1.1.2. Return on Assets

Shows how efficient Dermapharm Holding SE is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dermapharm Holding SE to the  industry mean.
  • 1.0% Return on Assets means that Dermapharm Holding SE generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dermapharm Holding SE:

  • The MRQ is 1.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.0%TTM3.3%-2.3%
TTM3.3%5Y3.3%0.0%
5Y3.3%10Y3.3%0.0%
1.1.3. Return on Equity

Shows how efficient Dermapharm Holding SE is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dermapharm Holding SE to the  industry mean.
  • 3.2% Return on Equity means Dermapharm Holding SE generated €0.03 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dermapharm Holding SE:

  • The MRQ is 3.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 9.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.2%TTM9.8%-6.6%
TTM9.8%5Y9.8%0.0%
5Y9.8%10Y9.8%0.0%

1.2. Operating Efficiency of Dermapharm Holding SE.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dermapharm Holding SE is operating .

  • Measures how much profit Dermapharm Holding SE makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dermapharm Holding SE to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dermapharm Holding SE:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Dermapharm Holding SE is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.23 means that the operating costs are €1.23 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Dermapharm Holding SE:

  • The MRQ is 1.227. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.083. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.227TTM1.083+0.144
TTM1.0835Y1.0830.000
5Y1.08310Y1.0830.000

1.3. Liquidity of Dermapharm Holding SE.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dermapharm Holding SE is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 2.20 means the company has €2.20 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Dermapharm Holding SE:

  • The MRQ is 2.203. The company is able to pay all its short-term debts. +1
  • The TTM is 2.847. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.203TTM2.847-0.644
TTM2.8475Y2.8470.000
5Y2.84710Y2.8470.000
1.3.2. Quick Ratio

Measures if Dermapharm Holding SE is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dermapharm Holding SE to the  industry mean.
  • A Quick Ratio of 0.56 means the company can pay off €0.56 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dermapharm Holding SE:

  • The MRQ is 0.558. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.564. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.558TTM0.564-0.006
TTM0.5645Y0.5640.000
5Y0.56410Y0.5640.000

1.4. Solvency of Dermapharm Holding SE.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dermapharm Holding SE assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dermapharm Holding SE to industry mean.
  • A Debt to Asset Ratio of 0.68 means that Dermapharm Holding SE assets are financed with 67.9% credit (debt) and the remaining percentage (100% - 67.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dermapharm Holding SE:

  • The MRQ is 0.679. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.660. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.679TTM0.660+0.019
TTM0.6605Y0.6600.000
5Y0.66010Y0.6600.000
1.4.2. Debt to Equity Ratio

Measures if Dermapharm Holding SE is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dermapharm Holding SE to the  industry mean.
  • A Debt to Equity ratio of 212.2% means that company has €2.12 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dermapharm Holding SE:

  • The MRQ is 2.122. The company is just not able to pay all its debts with equity.
  • The TTM is 1.960. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.122TTM1.960+0.163
TTM1.9605Y1.9600.000
5Y1.96010Y1.9600.000

2. Market Valuation of Dermapharm Holding SE

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Dermapharm Holding SE generates.

  • Above 15 is considered overpriced but always compare Dermapharm Holding SE to the  industry mean.
  • A PE ratio of 175.18 means the investor is paying €175.18 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dermapharm Holding SE:

  • The EOD is 146.846. Seems overpriced? -1
  • The MRQ is 175.177. Seems overpriced? -1
  • The TTM is 99.644. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD146.846MRQ175.177-28.331
MRQ175.177TTM99.644+75.534
TTM99.6445Y99.6440.000
5Y99.64410Y99.6440.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Dermapharm Holding SE.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Dermapharm Holding SE:

  • The MRQ is -111.299. Very Bad. -2
  • The TTM is 95.623. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ-111.299TTM95.623-206.922
TTM95.6235Y95.6230.000
5Y95.62310Y95.6230.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dermapharm Holding SE is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 5.59 means the investor is paying €5.59 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Dermapharm Holding SE:

  • The EOD is 4.684. Neutral. Compare to industry.
  • The MRQ is 5.587. Seems overpriced? -1
  • The TTM is 7.893. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD4.684MRQ5.587-0.904
MRQ5.587TTM7.893-2.306
TTM7.8935Y7.8930.000
5Y7.89310Y7.8930.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dermapharm Holding SE compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.5072.114-171%--2.114-171%2.114-171%
Book Value Growth---0.239-0.038-84%---0.038-84%-0.038-84%
Book Value Per Share--8.4558.903-5%--8.903-5%8.903-5%
Book Value Per Share Growth---0.1780.013-1519%--0.013-1519%0.013-1519%
Current Ratio--2.2032.847-23%--2.847-23%2.847-23%
Debt To Asset Ratio--0.6790.660+3%--0.660+3%0.660+3%
Debt To Equity Ratio--2.1221.960+8%--1.960+8%1.960+8%
Dividend Per Share----0%---0%-0%
Eps--0.2700.861-69%--0.861-69%0.861-69%
Eps Growth---1.574-0.785-50%---0.785-50%-0.785-50%
Gross Profit Margin--1.0001.0000%--1.0000%1.0000%
Net Profit Margin--0.0610.185-67%--0.185-67%0.185-67%
Operating Margin----0%---0%-0%
Operating Ratio--1.2271.083+13%--1.083+13%1.083+13%
Pb Ratio4.684-19%5.5877.893-29%--7.893-29%7.893-29%
Pe Ratio146.846-19%175.17799.644+76%--99.644+76%99.644+76%
Peg Ratio---111.29995.623-216%--95.623-216%95.623-216%
Price Per Share39.600-19%47.24069.498-32%--69.498-32%69.498-32%
Price To Total Gains Ratio-26.274+16%-31.34332.493-196%--32.493-196%32.493-196%
Profit Growth---170.675-87.668-49%---87.668-49%-87.668-49%
Quick Ratio--0.5580.564-1%--0.564-1%0.564-1%
Return On Assets--0.0100.033-69%--0.033-69%0.033-69%
Return On Equity--0.0320.098-67%--0.098-67%0.098-67%
Revenue Growth---0.017-0.063+269%---0.063+269%-0.063+269%
Total Gains Per Share---1.5072.114-171%--2.114-171%2.114-171%
Total Gains Per Share Growth---1.450-2.412+66%---2.412+66%-2.412+66%
Usd Book Value--478712506.800504077887.500-5%--504077887.500-5%504077887.500-5%
Usd Book Value Change Per Share---1.5852.223-171%--2.223-171%2.223-171%
Usd Book Value Per Share--8.8919.363-5%--9.363-5%9.363-5%
Usd Dividend Per Share----0%---0%-0%
Usd Eps--0.2840.905-69%--0.905-69%0.905-69%
Usd Price Per Share41.643-19%49.67873.084-32%--73.084-32%73.084-32%
Usd Profit--15268180.40048726937.600-69%--48726937.600-69%48726937.600-69%
Usd Revenue--251836116.400259293537.800-3%--259293537.800-3%259293537.800-3%
Usd Total Gains Per Share---1.5852.223-171%--2.223-171%2.223-171%
 EOD+4 -1MRQTTM+5 -26YOY+0 -05Y+5 -2610Y+5 -26

3.2. Fundamental Score

Let's check the fundamental score of Dermapharm Holding SE based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15146.846
Price to Book Ratio (EOD)Between0-14.684
Net Profit Margin (MRQ)Greater than00.061
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.558
Current Ratio (MRQ)Greater than12.203
Debt to Asset Ratio (MRQ)Less than10.679
Debt to Equity Ratio (MRQ)Less than12.122
Return on Equity (MRQ)Greater than0.150.032
Return on Assets (MRQ)Greater than0.050.010
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Dermapharm Holding SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose40.520
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,416,653
Total Liabilities961,430
Total Stockholder Equity452,994
 As reported
Total Liabilities 961,430
Total Stockholder Equity+ 452,994
Total Assets = 1,416,653

Assets

Total Assets1,416,653
Total Current Assets502,066
Long-term Assets502,066
Total Current Assets
Cash And Cash Equivalents 83,775
Short-term Investments 14,883
Net Receivables 112,187
Inventory 272,847
Other Current Assets 18,359
Total Current Assets  (as reported)502,066
Total Current Assets  (calculated)502,051
+/- 15
Long-term Assets
Goodwill 282,408
Intangible Assets 310,844
Long-term Assets Other 1
Long-term Assets  (as reported)914,587
Long-term Assets  (calculated)593,253
+/- 321,334

Liabilities & Shareholders' Equity

Total Current Liabilities227,913
Long-term Liabilities733,517
Total Stockholder Equity452,994
Total Current Liabilities
Short Long Term Debt 55,642
Accounts payable 53,150
Other Current Liabilities 32,927
Total Current Liabilities  (as reported)227,913
Total Current Liabilities  (calculated)141,719
+/- 86,194
Long-term Liabilities
Long term Debt 564,892
Capital Lease Obligations Min Short Term Debt13,704
Long-term Liabilities Other 11,206
Long-term Liabilities  (as reported)733,517
Long-term Liabilities  (calculated)589,802
+/- 143,715
Total Stockholder Equity
Retained Earnings 273,011
Total Stockholder Equity (as reported)452,994
Total Stockholder Equity (calculated)273,011
+/- 179,983
Other
Capital Stock53,840
Common Stock Shares Outstanding 53,840
Net Debt 536,759
Net Invested Capital 1,073,528
Net Working Capital 274,153



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-30
> Total Assets 
1,340,489
1,406,969
1,461,323
1,416,653
1,416,6531,461,3231,406,9691,340,489
   > Total Current Assets 
462,453
519,222
504,301
502,066
502,066504,301519,222462,453
       Cash And Cash Equivalents 
118,682
160,319
127,547
83,775
83,775127,547160,319118,682
       Short-term Investments 
12,372
11,742
4,971
14,883
14,8834,97111,74212,372
       Net Receivables 
82,057
72,517
91,332
112,187
112,18791,33272,51782,057
       Inventory 
238,486
240,535
268,218
272,847
272,847268,218240,535238,486
       Other Current Assets 
10,498
2,447
12,219
18,359
18,35912,2192,44710,498
   > Long-term Assets 
878,036
887,747
957,022
914,587
914,587957,022887,747878,036
       Goodwill 
266,397
264,730
324,351
282,408
282,408324,351264,730266,397
       Intangible Assets 
291,820
294,841
293,864
310,844
310,844293,864294,841291,820
> Total Liabilities 
914,541
907,135
924,953
961,430
961,430924,953907,135914,541
   > Total Current Liabilities 
160,830
155,613
169,569
227,913
227,913169,569155,613160,830
       Short Long Term Debt 
0
2,379
0
55,642
55,64202,3790
       Accounts payable 
52,014
52,101
60,080
53,150
53,15060,08052,10152,014
       Other Current Liabilities 
31,355
1,320
25,313
32,927
32,92725,3131,32031,355
   > Long-term Liabilities 
753,711
751,522
755,384
733,517
733,517755,384751,522753,711
       Capital Lease Obligations Min Short Term Debt
0
12,214
0
13,704
13,704012,2140
       Long-term Liabilities Other 
11,102
2,411
12,212
11,206
11,20612,2122,41111,102
> Total Stockholder Equity
423,201
497,316
534,085
452,994
452,994534,085497,316423,201
   Common Stock0000
   Retained Earnings 
266,306
337,954
375,325
273,011
273,011375,325337,954266,306
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 0000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue942,912
Cost of Revenue-322,218
Gross Profit620,694620,694
 
Operating Income (+$)
Gross Profit620,694
Operating Expense-655,869
Operating Income287,043-35,175
 
Operating Expense (+$)
Research Development14,174
Selling General Administrative65,882
Selling And Marketing Expenses-
Operating Expense655,86980,056
 
Net Interest Income (+$)
Interest Income4,022
Interest Expense-8,837
Net Interest Income-5,814-4,815
 
Pretax Income (+$)
Operating Income287,043
Net Interest Income-5,814
Other Non-Operating Income Expenses-
Income Before Tax (EBT)292,977287,043
EBIT - interestExpense = -8,837
209,583
218,420
Interest Expense8,837
Earnings Before Interest and Taxes (ebit)-301,814
Earnings Before Interest and Taxes (ebitda)357,410
 
After tax Income (+$)
Income Before Tax292,977
Tax Provision-84,073
Net Income From Continuing Ops208,904208,904
Net Income209,583
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-5,814
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DS2P.LSE
5 minutes ago

I found you a Death Cross on the daily chart of DS2P.LSE.

DS2P.LSE Daily Candlestick Chart
DQD.TO
6 minutes ago

I found you a Golden Cross on the daily chart of DQD.TO.

DQD.TO Daily Candlestick Chart
DNGDF.PINK
9 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of DNGDF.PINK.

DNGDF.PINK Daily Candlestick Chart
CU2G.LSE
16 minutes ago

I found you a Death Cross on the daily chart of CU2G.LSE.

CU2G.LSE Daily Candlestick Chart
CONTAINE.BSE
20 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CONTAINE.BSE.

CONTAINE.BSE Daily Candlestick Chart
CNXMEDIA.INDX
20 minutes ago

I found you a Golden Cross on the daily chart of CNXMEDIA.INDX.

CNXMEDIA.INDX Daily Candlestick Chart
CNCT.PINK
22 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CNCT.PINK.

CNCT.PINK Daily Candlestick Chart
CNA.LSE
22 minutes ago

I found you a Golden Cross on the daily chart of CNA.LSE.

CNA.LSE Daily Candlestick Chart
CGUSY.PINK
27 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CGUSY.PINK.

CGUSY.PINK Daily Candlestick Chart
CENQ.NASDAQ
28 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CENQ.NASDAQ.

CENQ.NASDAQ Daily Candlestick Chart
CAVR.PINK
30 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CAVR.PINK.

CAVR.PINK Daily Candlestick Chart
CAR.LSE
30 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of CAR.LSE.

CAR.LSE Daily Candlestick Chart
BVIC.LSE
33 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BVIC.LSE.

BVIC.LSE Daily Candlestick Chart
BRGC.PINK
37 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BRGC.PINK.

BRGC.PINK Daily Candlestick Chart
BLBLIMITED.BSE
40 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BLBLIMITED.BSE.

BLBLIMITED.BSE Daily Candlestick Chart
BIOR.NASDAQ
41 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BIOR.NASDAQ.

BIOR.NASDAQ Daily Candlestick Chart
BHL.LSE
41 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BHL.LSE.

BHL.LSE Daily Candlestick Chart
AAATECH.NSE
43 minutes ago

I found you a Death Cross on the daily chart of AAATECH.NSE.

AAATECH.NSE Daily Candlestick Chart
BBEG.MI
44 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BBEG.MI.

BBEG.MI Daily Candlestick Chart
AZ.V
46 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AZ.V.

AZ.V Daily Candlestick Chart
ASHNI.BSE
52 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of ASHNI.BSE.

ASHNI.BSE Daily Candlestick Chart
ASCCY.PINK
52 minutes ago

I found you a Golden Cross on the daily chart of ASCCY.PINK.

ASCCY.PINK Daily Candlestick Chart
ASDV.LSE
52 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASDV.LSE.

ASDV.LSE Daily Candlestick Chart
AMMX.OTCQB
55 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of AMMX.OTCQB.

AMMX.OTCQB Daily Candlestick Chart